BreakingManufacturing

Endotoxin and Sterility Tests: Why Passing One Is Not Enough

What endotoxin and sterility results each support, where sampling limits their interpretation, and why neither result alone establishes the evidence needed for batch release.

PHOTO ILLUSTRATION · PHARMADOSSIER

By Ran Chen·Updated October 17, 2026·12 min read

Latest in biopharma

An Insurance Change During Patient Assistance: Record the Program's Decision

By Ran Chen

Pricing & Access· October 15, 2026 · 29 min read

Copay Card Reimbursement After Paying Out of Pocket: What to File and When

By Ran Chen

Manufacturing· October 14, 2026 · 36 min read

Tablet Hold-Time Studies: How Long Can Granules, Blends and Bulk Wait?

By Ran Chen

Pricing & Access· October 13, 2026 · 14 min read

Specialty Drug Coinsurance: Reconcile the Estimate With the Claim

By Ran Chen

Pricing & Access· October 12, 2026 · 18 min read

Prior Authorization Approved but Quantity Rejected: Reconcile Before Escalating

By Ran Chen

Manufacturing· October 11, 2026 · 15 min read

Pharmaceutical Water Results: TOC and Conductivity Do Not Replace Microbial Evidence

By Ran Chen

Manufacturing· October 10, 2026 · 14 min read

Returned Drug Lots: When to Reprocess or Destroy Under CGMP

By Ran Chen

The PharmaDossier Daily

The eight-minute biopharma briefing for access, regulatory, and commercial teams.

Launch signals, payer moves, biosimilar reads, and FDA source links every weekday.

Browse topics

Sections

Topic watch

Coverage Access173 Prior Authorization172 Payer Policy150 FDA Approval147 Specialty Pharmacy89 Formulary Strategy79 Specialty Drugs76 Oncology74 Clinical Evidence73 GLP-167 Biosimilars66 Drug Pricing66 Orange Book65 Market Access61

Editorial standard

Every article links back to FDA, CMS, DailyMed, Purple Book, Orange Book, ClinicalTrials.gov, or another primary source wherever the claim depends on regulated status.

Lead editor: Founder, PharmaDossier. Life-sciences operator covering market access, specialty pharma, biosimilars, and regulated healthcare growth.